Invitation to Participate in Two New ILSI HESI DART Surveys

Survey of Predictive Value of Nonclinical Studies for Reproductive Findings in Men. The Developmental and Reproductive Toxicology (DART) Technical Committee at the ILSI Health and Environmental Sciences Institute (HESI) has launched a survey toward understanding the predictivity of adverse findings in nonclinical male fertility studies to clinical outcomes in men. We are seeking data on compounds that showed adverse findings in any nonhuman species and have data available from clinical trials in any male reproduction endpoint. The survey is open to all who are willing to contribute data. To learn more about or to participate in the survey, please contact Connie Chen (cchen@hesiglobal.org).

Survey of Nonclinical Model of Neonatal/Pediatric Therapeutics. The Developmental and Reproductive Toxicology (DART) Technical Committee at the ILSI Health and Environmental Sciences Institute (HESI) has formed a multi-sector workgroup on the best use of nonclinical approaches for neonatal medicine development. The workgroup has designed a survey towards identifying available nonclinical neonatal pediatric models that may inform the efficacy and long-term safety and tolerability of neonatal drug therapy. The survey is open to all researchers across industry, regulatory agencies, and research institutes who are willing to contribute data. To learn more about or to participate in the survey, please contact Connie Chen (cchen@hesiglobal.org). The full survey is also available online (online survey link).

Recent Stories
Free Webinar: The Veterinary Pathologist’s Role in the 3Rs, September 19 at 11 am ET

Press Release: Advances in 3-D Printing Launch a Promising Future for Birth Defects Treatments

Grant Opportunity: Advancing Actionable Alternatives to Vertebrate Animal Testing for Chemical Safety Assessment